Welcome to CDC stacks | Interstitial contacts in an RNA-dependent RNA polymerase lattice - 33290 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All Simple Search
Advanced Search
Interstitial contacts in an RNA-dependent RNA polymerase lattice
Filetype[PDF-2.97 MB]

  • Pubmed ID:
  • Pubmed Central ID:
  • Description:
    Catalytic activities can be facilitated by ordered enzymatic arrays that co-localize and orient enzymes and their substrates. The purified RNA-dependent RNA polymerase from poliovirus self-assembles to form two-dimensional lattices, possibly facilitating the assembly of viral RNA replication complexes on the cytoplasmic face of intracellular membranes. Creation of a two-dimensional lattice requires at least two different molecular contacts between polymerase molecules. One set of polymerase contacts, between the "thumb" domain of one polymerase and the back of the "palm" domain of another, has been previously defined. To identify the second interface needed for lattice formation and to test its function in viral RNA synthesis, we used a hybrid approach of electron microscopic and biochemical evaluation of both wild-type and mutant viral polymerases to evaluate computationally generated models of this second interface. A unique solution satisfied all constraints and predicted a two-dimensional structure formed from antiparallel arrays of polymerase fibers that use contacts from the flexible amino-terminal region of the protein. Enzymes that contained mutations in this newly defined interface did not form lattices and altered the structure of wild-type lattices. When reconstructed into virus, mutations that disrupt lattice assembly exhibited growth defects, synthetic lethality or both, supporting the function of the oligomeric lattice in infected cells. Understanding the structure of polymerase lattices within the multimeric RNA-dependent RNA polymerase complex should facilitate antiviral drug design and provide a precedent for other positive-strand RNA viruses.

  • Document Type:
  • Collection(s):
  • Funding:
    DP1 827/DP/NCCDPHP CDC HHS/United States
    DP1 OD000827/OD/NIH HHS/United States
    DP1 OD000827-05/OD/NIH HHS/United States
    GM55722/GM/NIGMS NIH HHS/United States
    R01 GM055722/GM/NIGMS NIH HHS/United States
    R01 GM055722-09/GM/NIGMS NIH HHS/United States
    S10 RR025434/RR/NCRR NIH HHS/United States
    S10 RR025434-01/RR/NCRR NIH HHS/United States
    T32 AI007328/AI/NIAID NIH HHS/United States
    T32 AI007328-21/AI/NIAID NIH HHS/United States
    T32 AI07328/AI/NIAID NIH HHS/United States
No Related Documents.
You May Also Like: